Investors Apparently Not Sold on Amgen’s Lung Cancer Drug

Investors Apparently Not Sold on Amgen’s Lung Cancer Drug

Invest with an Option to Buy: Bristol-Myers Squibb Partners with Accelerator BioMotiv

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    Bristol-Myers Squibb has partnered with biotech accelerator BioMotiv. Bristol-Myers will become a limited partner, investing in projects of mutual interest, with an option to buy the companies once there is a preclinical candidate. “This new partnership will allow us to leverage the extensive expertise …

Report: Projected Sales of 10 Top-Selling Drugs Through 2024

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    Although some of the top-selling drugs in the world are facing patent cliffs between now and then, many of them are still projected to continue being big sellers between now and 2024. A recent report by Evaluate Pharma estimates prescription drug sales will …

Απορρίφθηκε φάρμακο της Amgen

Απορρίφθηκε φάρμακο της Amgen

Eli Lilly Wins FDA Approval for First Episodic Cluster Headache Treatment

Eli Lilly Wins FDA Approval for First Episodic Cluster Headache Treatment

Asco 2019 event analyser – low-key meeting belies some huge stock moves

Asco 2019 event analyser – low-key meeting belies some huge stock moves

All the ASCO skinny: Lynparza’s pancreatic win, Amgen’s KRAS spotlight, Merck’s history-busting and more

All the ASCO skinny: Lynparza's pancreatic win, Amgen's KRAS spotlight, Merck's history-busting and more

ASCO 2019 – Abstract drop fires the starting gun

ASCO 2019 – Abstract drop fires the starting gun

Boehringer Ingelheim and AbbVie Resolve Humira Biosimilar Patent Litigation

Boehringer Ingelheim and AbbVie Resolve Humira Biosimilar Patent Litigation

Νέο φάρμακο μειώνει τον καρδιαγγειακό κίνδυνο

Νέο φάρμακο μειώνει τον καρδιαγγειακό κίνδυνο